| ELYM Shares Outstanding History Table | ||||||||||||||||||||||||
Below is a table of the ELYM shares outstanding history going back to 9/10/2021:
Also see: ELYM Market Cap History ELYM YTD Return |
ELYM Shares Outstanding History — Eliem Therapeutics Share Count Over Time
As of 8/12/2024 Eliem Therapeutics has 67.06 million ELYM shares outstanding. Investors often track the ELYM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ELYM share count trends over time, with 11 historical shares outstanding datapoints presented, dating back to 9/10/2021.
| ELYM Shares Outstanding History Chart | |||||||||||||||||||||||||
ELYM Historical Shares Outstanding: +37.30% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||
| ELYM Stock Price Chart |
| About Climb Bio Inc |
| Eliem Therapeutics is a clinical-stage biotechnology company focused on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Co. is developing a pipeline of clinically differentiated product candidates focused on validated mechanisms of action with therapeutic potential to deliver therapeutics for patients with these disorders. Co.'s two clinical-stage candidates are ETX-810 and ETX-155. ETX-810 is a palmitoylethanolamide prodrug for the treatment of diabetic peripheral neuropathic pain and lumbosacral radicular pain, commonly referred to as sciatica. We show 11 historical shares outstanding datapoints in our coverage of ELYM's shares outstanding history. Understanding the changing numbers of ELYM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELYM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELYM by allowing them to research ELYM shares outstanding history as well as any other stock in our coverage universe. |
| ELYM Current Stock Quote |
Quotes delayed 20 minutes  Free ELYM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ELYM Share Performance |
| Shares Outstanding Peers |
| Eliem Therapeutics (ELYM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
EMBC Shares Outstanding History EMMA Shares Outstanding History ENDP Shares Outstanding History ENOB Shares Outstanding History ENOV Shares Outstanding History ENSC Shares Outstanding History ENSG Shares Outstanding History ENTA Shares Outstanding History ENTO Shares Outstanding History ENVB Shares Outstanding History More Healthcare companies » |
ELYM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
